Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iota-Carrageenan Nasal Spray for COVID-19 Prophylaxis in Healthcare Workers
NCT04521322Phase 4Unknown
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of Iota-carrageenan in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
Iota-carrageenan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04521322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521322.